Alonso Krangle LLP Warns NuvaRing Users of Potentially Deadly NuvaRing Side Effects, Including Blood Clots, Thrombosis, Pulmonary Embolism, Heart Attacks, and Strokes

Share Article

According to Two Recent Studies, NuvaRing Side Effects May Include Increased Risk of Serious Blood Clots, Including Pulmonary Embolism and Deep Vein Thrombosis, which can Result in Heart Attacks, Strokes and Wrongful Death

Alonso Krangle LLP - Is alerting NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) users of the potential for serious, life-threatening NuvaRing blood clots and other dangerous NuvaRing side eff

Alonso Krangle LLP - Is alerting NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) users of the potential for serious, life-threatening NuvaRing blood clots and other dangerous NuvaRing side eff

To discuss a potential claim with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims of defective medical devices, are alerting NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) users of the potential for serious, life-threatening NuvaRing blood clots and other dangerous NuvaRing side effects. Two recent studies, one commissioned by the U.S. Food & Drug Administration (FDA) and released in October 2011, and the other reported earlier this month by the British Medical Journal, have found that NuvaRing significantly raises the risk of serious blood clots, including deep vein thrombosis and pulmonary embolism, compared to hormonal birth control pills. These types of blood clots can lead to heart attacks, strokes and even sudden death.

Alonso Krangle is currently offering free NuvaRing lawsuit consultations to victims of NuvaRing side effects, including:

  •      Blood clots
  •     Deep vein thrombosis
  •     Pulmonary embolism
  •     Heart attacks
  •     Strokes
  •     Wrongful death

To discuss a potential claim with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.
NuvaRing is a hormonal contraceptive device that releases a combination of etonogestrel, a synthetic generation progestin, and the estrogen, ethinyl estradiol. Introduced in 2001 by Merck & Co.’s Organon subsidiary, NuvaRing is a small flexible ring that is designed to be inserted into the vagina once a month. It is kept in place for three weeks, and prevents pregnancy by releasing controlled amounts of those hormones into the bloodstream.

Last October, results from an FDA-funded study that involved 800,000 American women using some form birth control between 2001 and 2008 revealed using NuvaRing increased the risk of blood clots, including deep vein thrombosis and pulmonary embolism, by 56% in comparison to older birth control pills. The FDA study noted that combined hormonal contraceptives, including the etonogestrel/ethinyl estradiol vaginal ring, “potentially result in higher sustained exposure to estrogen and hence, increased thromboembolic risk.” [fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf]

A second study, published on May 10, 2012 in the online edition of the British Medical Journal, found that NuvaRing users had a 6.5 times higher risk of experiencing a serious blood clot compared to women who did not use any form of hormonal birth control. By way of comparison, the study found that users of birth control pills containing the hormone levonorgestrel face only a 3-times higher blood clot risk than those using no hormonal birth control method. The likelihood of experiencing a dangerous blood clot was 90% higher among users of the vaginal ring than it was for women taking combined oral contraceptives containing levonorgestrel. The authors of the report concluded that women would be best advised to use standard hormonal birth control pills. [bmj.com/content/344/bmj.e2990]

More than 900 lawsuits alleging NuvaRing caused serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes and wrongful death are currently pending in a multidistrict litigation before Rodney W. Sippel of the U.S. District Court, Eastern District of Missouri (MDL No. 1964). Additional NuvaRing lawsuits pending in a Mass Tort proceeding in the Bergen County Superior Court of New Jersey (Docket No. BER-L-3081-09).
There is still time for young women who may have been injured by NuvaRing, or their families, to file personal injury lawsuits seeking compensation for medical bills, pain and suffering, emotional distress and other damages. To discuss a potential claim with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice, whistleblower actions, employee rights, and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website